C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 207/404 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) C07D 207/263 (2006.01) C07D 207/448 (2006.01) C07D 209/44 (2006.01) C07D 209/48 (2006.01) C07D 209/52 (2006.01) C07D 401/06 (2006.01) C07D 403/06 (2006.01)
Patent
CA 2233975
Novel succinimides and maleimides are inhibitors or tumor necrosis factor .alpha. and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions. A typical embodiment is methyl 3-(3',4',5',6'-tetrahydrophthalimido)-(3",4"-dimethoxyphenyl)propionate. The novel compounds have the following formula: (see formula I) in which: R1 is -CH2-, -CH2CO-, or -CO-; R2, R3, R4 and R5 are more fully described in the disclosure.
L'invention concerne de nouveaux succinimides et maléimides inhibiteurs du facteur de nécrose tumorale alpha et de la phosphodiestérase, que l'on peut utiliser pour traiter la cachexie, le choc endotoxique, la réplication de rétrovirus, l'asthme et les maladies inflammatoires. Dans une variante classique, il se présente sous la forme méthyle 3-(3',4',5',6'-tétrahydrophtalimido)-3-(4",4"-diméthoxyphényl)propionate.
Muller George W.
Shire Mary
Celgene Corporation
Goudreau Gage Dubuc
Muller George W.
Shire Mary
LandOfFree
Succinimide and maleimide cytokine inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Succinimide and maleimide cytokine inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Succinimide and maleimide cytokine inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1858650